Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.

Senn N, Rarau P, Stanisic DI, Robinson L, Barnadas C, Manong D, Salib M, Iga J, Tarongka N, Ley S, Rosanas-Urgell A, Aponte JJ, Zimmerman PA, Beeson JG, Schofield L, Siba P, Rogerson SJ, Reeder JC, Mueller I.

PLoS Med. 2012;9(3):e1001195. doi: 10.1371/journal.pmed.1001195. Epub 2012 Mar 27. Erratum in: PLoS Med. 2012 Jun;9(6). doi:10.1371/annotation/de06fdd3-c263-416c-8b5f-291f9c474558.

2.

Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children.

Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM.

PLoS One. 2011;6(12):e29203. doi: 10.1371/journal.pone.0029203. Epub 2011 Dec 22.

3.

Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM.

PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932.

4.

Glycophorin C delta(exon3) is not associated with protection against severe anaemia in Papua New Guinea.

Tavul L, Mueller I, Rare L, Lin E, Zimmerman PA, Reeder J, Siba P, Michon P.

P N G Med J. 2008 Sep-Dec;51(3-4):149-54.

PMID:
21061946
5.

Robert Koch redux: malaria immunology in Papua New Guinea.

Stanisic DI, Mueller I, Betuela I, Siba P, Schofield L.

Parasite Immunol. 2010 Aug;32(8):623-32. doi: 10.1111/j.1365-3024.2010.01238.x. Review.

6.

Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

Bönsch C, Kempf C, Mueller I, Manning L, Laman M, Davis TM, Ros C.

PLoS Negl Trop Dis. 2010 Apr 27;4(4):e669. doi: 10.1371/journal.pntd.0000669.

7.

Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study.

Wildig J, Cossart Y, Peshu N, Gicheru N, Tuju J, Williams TN, Newton CR.

BMC Infect Dis. 2010 Apr 3;10:88. doi: 10.1186/1471-2334-10-88.

8.

Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.

Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, Laumaea A, Schöpflin S, Stanisic D, Betuela I, Blood-Zikursh M, Siba P, Felger I, Schofield L, Zimmerman P, Mueller I.

PLoS One. 2010 Feb 4;5(2):e9047. doi: 10.1371/journal.pone.0009047.

9.

Malaria, erythrocytic infection, and anemia.

Haldar K, Mohandas N.

Hematology Am Soc Hematol Educ Program. 2009:87-93. doi: 10.1182/asheducation-2009.1.87. Review.

10.

Malaria and vitamin A deficiency in African children: a vicious circle?

Sanjoaquin MA, Molyneux ME.

Malar J. 2009 Jun 17;8:134. doi: 10.1186/1475-2875-8-134. Review.

11.

Vivax malaria: a major cause of morbidity in early infancy.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Clin Infect Dis. 2009 Jun 15;48(12):1704-12. doi: 10.1086/599041.

12.

High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea.

Mueller I, Widmer S, Michel D, Maraga S, McNamara DT, Kiniboro B, Sie A, Smith TA, Zimmerman PA.

Malar J. 2009 Mar 11;8:41. doi: 10.1186/1475-2875-8-41.

13.

Point and interval estimation of partial attributable risks from case-control data using the R-package 'pARccs'.

Rämsch C, Pfahlberg AB, Gefeller O.

Comput Methods Programs Biomed. 2009 Apr;94(1):88-95. doi: 10.1016/j.cmpb.2008.10.006. Epub 2008 Dec 4.

PMID:
19062126
14.

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.

Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN.

PLoS Med. 2008 Jun 17;5(6):e128. doi: 10.1371/journal.pmed.0050128.

15.

Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children.

Calis JC, Rotteveel HP, van der Kuyl AC, Zorgdrager F, Kachala D, van Hensbroek MB, Cornelissen M.

BMC Infect Dis. 2008 Feb 29;8:26. doi: 10.1186/1471-2334-8-26.

16.

Severe anemia in Malawian children.

Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, Cuevas LE, de Haan RJ, Phiri AI, Malange P, Khoka M, Hulshof PJ, van Lieshout L, Beld MG, Teo YY, Rockett KA, Richardson A, Kwiatkowski DP, Molyneux ME, van Hensbroek MB.

N Engl J Med. 2008 Feb 28;358(9):888-99. doi: 10.1056/NEJMoa072727.

17.

Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial.

Zeba AN, Sorgho H, Rouamba N, Zongo I, Rouamba J, Guiguemdé RT, Hamer DH, Mokhtar N, Ouedraogo JB.

Nutr J. 2008 Jan 31;7:7. doi: 10.1186/1475-2891-7-7.

18.

The risk of malarial infections and disease in Papua New Guinean children.

Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I.

Am J Trop Med Hyg. 2007 Jun;76(6):997-1008.

19.

Promoter polymorphism of the anion-exchange protein 1 associated with severe malarial anemia and fatality.

von Kalckreuth V, Evans JA, Timmann C, Kuhn D, Agbenyega T, Horstmann RD, May J.

J Infect Dis. 2006 Oct 1;194(7):949-57. Epub 2006 Aug 30.

PMID:
16960783
20.

Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea.

Wildig J, Michon P, Siba P, Mellombo M, Ura A, Mueller I, Cossart Y.

J Infect Dis. 2006 Jul 15;194(2):146-53. Epub 2006 Jun 14.

PMID:
16779719

Supplemental Content

Support Center